Related Experiment Videos
Observations on Indian node-negative breast cancer patients: a multivariate analysis.
J J Vyas1, P B Desai, M B Sampat
1Tata Memorial Hospital, Bombay, India.
Journal of Surgical Oncology
|December 1, 1989
Summary
Identifying prognostic factors for long-term breast cancer failures in patients with negative lymph nodes (N-) is crucial. Further research and clinical trials are needed to pinpoint high-risk N- patients for adjuvant chemotherapy consideration.
Area of Science:
- Oncology
- Breast Cancer Research
- Clinical Prognostics
Background:
- Breast cancer treatment has evolved significantly over the last century.
- Axillary lymph node status is a key prognostic factor.
- Identifying high-risk patients within the histologically node-negative (N-) group remains a challenge.
Purpose of the Study:
- To retrospectively analyze prognostic factors for long-term treatment failures in node-negative (N-) breast cancer patients.
- To identify key indicators of risk in N- patients despite negative lymph node biopsies.
- To inform future strategies for risk stratification and adjuvant therapy decisions.
Main Methods:
- Retrospective analysis of prognostic factors.
- Focus on patients with histologically negative lymph nodes (N-).
- Evaluation of factors contributing to long-term treatment failures.
Main Results:
- The number of positive axillary lymph nodes (N+) is an established prognostic factor.
- Specific prognostic factors for long-term failures in N- patients require detailed investigation.
- Current data necessitates further study to accurately identify high-risk N- individuals.
Conclusions:
- Accurate identification of high-risk N- breast cancer patients is essential for personalized treatment.
- Further detailed study of prognostic factors in N- patients is warranted.
- Controlled clinical trials are recommended to guide adjuvant chemotherapy decisions for high-risk N- patients.